FRANKFURT (Reuters) – Drugmaker Bayer AG said on Tuesday it will this month file for approval of its experimental haemophilia drug Bay 81-8973, based on its established Kogenate brand, as it seeks to build a range of treatments against the hereditary bleeding disorder.
The German…
Bayer to seek approval for haemophilia drug this month
No comments:
Post a Comment